USPTO serial 87787266
X-BACS CLINI
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEELEY, ALISON REBECCA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with X-BACS CLINI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Rancho Cordova, CA
Rancho Cordova, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashley Hatzenbihler
Ashley Hatzenbihler McDonnell Boehnen Hulbert & Berghoff LLP300 South Wacker Drive, Suite 3100Chicago, IL 60606United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Kits consisting primarily of an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use, microbubbles being diagnostic preparations for clinical or medical laboratory use, buffers being chemicals used in the biotechnology fields, blood component separators being chemical reagents for laboratory use, and also consisting of Scientific apparatuses for automated and integrated cell washing and fluid transfer devices to wash and concentrate blood cell products in the nature of filters for blood for medical laboratory use, syringes filled with saline, empty syringes, syringe caps, needles, with all of the foregoing for medical laboratory and research use | ACTIVE | — |
| 005 | Kits consisting primarily of blood component separators in the nature of solutions for medical and clinical use in storing and treating cells, blood and blood components, and syringes filled with saline for medical use and also consisting of empty syringes, syringe caps, needles, with all of the foregoing for medical use | ACTIVE | — |
| 009 | Kits consisting primarily of blood component separators in the nature of filters for blood and blood components for laboratory use and scientific apparatuses for automated and integrated cell washing and fluid transfer devices to wash and concentrate blood cell products all of the foregoing for medical laboratory use and also consisting of syringes filled with saline, empty syringes, syringe caps, needles, with all of the foregoing for medical laboratory use | ACTIVE | — |
| 010 | Kits consisting primarily of blood component separators in the nature of Filters for blood and blood components for medical purposes and Scientific apparatuses for automated and integrated cell washing and fluid transfer devices to wash and concentrate blood cell products in order to process human whole blood for the purpose of separating human blood components for use in blood transfusions, and also consisting of empty syringes, syringe caps and needles, with all of the foregoing for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Thermogenesis Corp.
- Other trademarks owned by Thermogenesis Corp.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named X-BACS CLINI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 15, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 15, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 15, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 7, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 30, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 28, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 28, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 28, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 4, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 1, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 31, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2018 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 23, 2018 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 23, 2018 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| May 23, 2018 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| May 18, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 15, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2018 | NWAP | NEW APPLICATION ENTERED | — |